Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-13

Clinical Trial Update: The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome )

View source ↗

Summary

This completed clinical trial evaluates whether serum microRNA-21-5p and LncRNAgadd7 expression levels can predict the severity and prognosis of acute respirato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shao Yuekai | Conditions: Acute Respiratory Distress Syndrome | Status: COMPLETED